文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
作者信息
Ehrly A M
出版信息
J Med. 1979;10(5):331-8.
PMID:
294470
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
MCP 服务
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2025
相似文献
1
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
J Med. 1979;10(5):331-8.
2
[Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
Ric Clin Lab. 1981;11 Suppl 1:265-79.
3
Pentoxifylline -- a biomedical profile.
J Med. 1979;10(5):307-29.
4
[Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Dtsch Med Wochenschr. 1978 Apr 21;103(16):694-8. doi: 10.1055/s-0028-1104502.
5
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Clin Ter. 1983 Feb 28;104(4):297-304.
6
[Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Z Gesamte Inn Med. 1987 Mar 1;42(5):137-41.
7
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Angiology. 1976 Mar;27(3):188-96. doi: 10.1177/000331977602700306.
8
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
[慢性动脉闭塞性疾病中的血小板功能、血浆凝血及纤维蛋白溶解。己酮可可碱研究]
Med Welt. 1979 Aug 24;30(34):1239-43.
9
[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Ric Clin Lab. 1983;13 Suppl 3:459-64.
10
Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
J Med. 1979;10(5):347-64.
引用本文的文献
1
Antimetastatic Action of Pentoxifylline, a Methyl Xanthine Derivative, Through its Effect on PKC Mediated Integrin Transport in B16F10 Melanoma Cells.
甲基黄嘌呤衍生物己酮可可碱对B16F10黑色素瘤细胞中蛋白激酶C介导的整合素转运的影响及其抗转移作用
World J Oncol. 2010 Oct;1(5):194-203. doi: 10.4021/wjon252e. Epub 2010 Nov 2.
2
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
急性肺损伤和急性呼吸窘迫综合征的药物治疗
Curr Med Chem. 2008;15(19):1911-24. doi: 10.2174/092986708785132942.
3
Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
己酮可可碱抑制超抗原诱导的中毒性休克和细胞因子释放。
Clin Diagn Lab Immunol. 1999 Jul;6(4):594-8. doi: 10.1128/CDLI.6.4.594-598.1999.
4
Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells.
己酮可可碱及其衍生物对人吞噬细胞摄取抗生素和产生超氧化物的影响。
Antimicrob Agents Chemother. 1995 Jul;39(7):1574-9. doi: 10.1128/AAC.39.7.1574.
5
Effect of pentoxifylline on single red cell deformability.
Klin Wochenschr. 1981 Nov 16;59(22):1271-2. doi: 10.1007/BF01747760.
6
Effect of nitroglycerin on blood rheology in healthy subjects.
硝酸甘油对健康受试者血液流变学的影响。
Eur J Clin Pharmacol. 1985;29(3):331-6. doi: 10.1007/BF00544090.
7
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.
英国药理学会临床药理学分会会议记录。爱尔兰,1988年7月6日至8日。摘要。
Br J Clin Pharmacol. 1988 Nov;26(5):615P-678P.
8
Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.
己酮可可碱对人多形核白细胞质膜功能的调节作用
Infect Immun. 1989 Nov;57(11):3520-6. doi: 10.1128/iai.57.11.3520-3526.1989.
9
Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases.
Agents Actions. 1991 Jul;33(3-4):254-9. doi: 10.1007/BF01986571.
10
Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
氟碳乳剂-DA/卡波金与氯硝胺或己酮可可碱作为FSaIIC纤维肉瘤中烷化剂的调节剂
Cancer Chemother Pharmacol. 1991;28(1):45-50. doi: 10.1007/BF00684955.